Profile data is unavailable for this security.
About the company
Pharma Foods International Co., Ltd. is a Japan-based company mainly engaged in mail order business and functional materials business. The Company operates through three business segments. The Mail Order segment is engaged in the sale of supplement Tamagosamin, cosmetics Pearl Skin Lanchel and Derma QII Mild Peeling Gel, through advertising media such as televisions and radios. The Functional Materials segment is engaged in the development and sale of functional materials such as GABA, Bonepep, Folic Acid eggs and Chicken Egg Antibody. The Company is also engaged in the planning and sale of original equipment manufacturer (OEM) products such as supplements and beverages. The Biomedical segment is engaged in the antibody contract manufacture business for drug discovery and diagnostics, and life science information (LSI) business for analysis and efficacy evaluation test of materials and products.
- Revenue in JPY (TTM)62.15bn
- Net income in JPY3.21bn
- Incorporated1997
- Employees670.00
- LocationPharma Foods International Co Ltd1-49, Goryo Ohara, Nishikyo-KuKYOTO-SHI 615-8245JapanJPN
- Phone+81 753948600
- Fax+81 753940099
- Websitehttps://www.pharmafoods.co.jp/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nano Mrna Co Ltd | 76.60m | -650.31m | 12.64bn | 18.00 | -- | 3.87 | -- | 165.04 | -9.24 | -9.24 | 1.09 | 46.27 | 0.0145 | 24.08 | 1.45 | 4,255,556.00 | -12.33 | -24.16 | -13.57 | -25.17 | 78.30 | 84.69 | -848.97 | -600.70 | 9.24 | -- | 0.2540 | -- | -32.98 | -22.88 | 40.50 | -- | -- | -- |
PRISM BioLab Co Ltd | -100.00bn | -100.00bn | 13.99bn | 22.00 | -- | 6.62 | -- | -- | -- | -- | -- | 58.79 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -79.63 | -- | -822.18 | -- | -- | -- |
AnGes Inc | 449.34m | -6.11bn | 14.64bn | 145.00 | -- | 0.5311 | -- | 32.58 | -29.92 | -29.92 | 2.22 | 107.33 | 0.0139 | 0.1931 | 4.02 | 3,098,862.00 | -18.95 | -28.50 | -22.32 | -33.14 | 38.79 | 39.42 | -1,359.35 | -6,726.82 | 1.19 | -- | 0.013 | -- | 128.13 | -24.17 | 49.45 | -- | 12.11 | -- |
Healios KK | 522.00m | -5.39bn | 19.20bn | 64.00 | -- | 5.92 | -- | 36.78 | -68.16 | -68.16 | 6.56 | 36.00 | 0.0321 | -- | 1.61 | 8,156,250.00 | -33.11 | -23.55 | -49.17 | -28.52 | 85.06 | -- | -1,030.65 | -6,580.16 | -- | -1.49 | 0.7469 | -- | 34.44 | -- | 26.04 | -- | -22.00 | -- |
Pharma Foods International Co., Ltd. | 62.15bn | 3.21bn | 24.95bn | 670.00 | 7.56 | 2.08 | 6.07 | 0.4015 | 113.47 | 113.47 | 2,185.12 | 412.69 | 1.71 | 2.10 | 14.00 | -- | 8.81 | 8.63 | 25.38 | 22.06 | 78.45 | 80.64 | 5.16 | 4.13 | 0.8875 | 81.16 | 0.5932 | 26.28 | -9.37 | 42.62 | 4.02 | 45.01 | 28.23 | -- |
Chordia Therapeutics Inc | -100.00bn | -100.00bn | 25.14bn | 21.00 | -- | 6.32 | -- | -- | -- | -- | -- | 58.88 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 112.55 | -- | -- | -- |
Heartseed Inc | -100.00bn | -100.00bn | 33.67bn | 39.00 | -- | 5.46 | -- | -- | -- | -- | -- | 277.47 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 20.01 | -- | 0.0011 | -- | -30.93 | -- | -4.30 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Nomura Asset Management Co., Ltd.as of 31 May 2024 | 823.80k | 2.83% |
The Vanguard Group, Inc.as of 30 Jun 2024 | 816.57k | 2.81% |
Nikko Asset Management Co., Ltd.as of 05 Jul 2024 | 383.50k | 1.32% |
Daiwa Asset Management Co. Ltd.as of 28 Jun 2024 | 363.30k | 1.25% |
Norges Bank Investment Managementas of 31 Dec 2023 | 359.90k | 1.24% |
Dimensional Fund Advisors LPas of 04 Jul 2024 | 254.00k | 0.87% |
SSgA Funds Management, Inc.as of 03 Jul 2024 | 165.70k | 0.57% |
Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Jul 2024 | 160.70k | 0.55% |
BlackRock Fund Advisorsas of 03 Jul 2024 | 82.50k | 0.28% |
Invesco Asset Management (Japan) Ltd.as of 27 Apr 2023 | 75.30k | 0.26% |